Healthcare provider profile · identity verified

Trinity Vallejo

Internal Medicine · GARDEN CITY, KS · NPI 1952833519

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	749	148
Atorvastatin Calcium	Atorvastatin Calcium	743	192
Losartan Potassium	Losartan Potassium	485	127
Amlodipine Besylate	Amlodipine Besylate	467	131
Gabapentin	Gabapentin	417	84
Pantoprazole Sodium	Pantoprazole Sodium	348	91
Furosemide	Furosemide	312	83
Eliquis	Apixaban	256	32
Metformin Hcl	Metformin Hcl	245	65
Pravastatin Sodium	Pravastatin Sodium	235	63
Lisinopril	Lisinopril	224	57
Potassium Chloride	Potassium Chloride	212	56
Omeprazole	Omeprazole	193	43
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	192	32
Escitalopram Oxalate	Escitalopram Oxalate	186	30
Metoprolol Succinate	Metoprolol Succinate	180	51
Spironolactone	Spironolactone	173	43
Jardiance	Empagliflozin	172	36
Metoprolol Tartrate	Metoprolol Tartrate	172	49
Tamsulosin Hcl	Tamsulosin Hcl	172	45
Alendronate Sodium	Alendronate Sodium	168	43
Ozempic	Semaglutide	167	29
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	166	29
Metformin Hcl Er	Metformin Hcl	166	47
Duloxetine Hcl	Duloxetine Hcl	160	31
Warfarin Sodium	Warfarin Sodium	154	17
Rosuvastatin Calcium	Rosuvastatin Calcium	151	48
Famotidine	Famotidine	136	27
Montelukast Sodium	Montelukast Sodium	123	26
Simvastatin	Simvastatin	123	36
Carvedilol	Carvedilol	115	37
Tramadol Hcl	Tramadol Hcl	114	28
Hydroxyzine Hcl	Hydroxyzine Hcl	113	26
Hydrochlorothiazide	Hydrochlorothiazide	112	39
Allopurinol	Allopurinol	106	26
Pregabalin	Pregabalin	105	17
Ezetimibe	Ezetimibe	104	33
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	103	18
Trazodone Hcl	Trazodone Hcl	103	19
Clopidogrel	Clopidogrel Bisulfate	101	26
Glipizide Er	Glipizide	100	31
Alprazolam	Alprazolam	93	17
Sertraline Hcl	Sertraline Hcl	92	23
Albuterol Sulfate Hfa	Albuterol Sulfate	91	41
Mounjaro	Tirzepatide	85	12
Pioglitazone Hcl	Pioglitazone Hcl	85	22
Levetiracetam	Levetiracetam	83	11
Atenolol	Atenolol	80	18
Mirtazapine	Mirtazapine	79	14
Trulicity	Dulaglutide	79	15
Venlafaxine Hcl Er	Venlafaxine Hcl	76	18
Diclofenac Sodium	Diclofenac Sodium	73	13
Fluticasone Propionate	Fluticasone Propionate	73	27
Donepezil Hcl	Donepezil Hcl	72	12
Estradiol	Estradiol	66	16
Finasteride	Finasteride	66	19
Xarelto	Rivaroxaban	64	12
Zolpidem Tartrate	Zolpidem Tartrate	63	suppressed
Meloxicam	Meloxicam	61	19
Glimepiride	Glimepiride	58	15
Lovastatin	Lovastatin	54	13
Novolog Flexpen	Insulin Aspart	53	18
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	52	suppressed
Oxycodone Hcl	Oxycodone Hcl	51	15
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	49	suppressed
Nifedipine Er	Nifedipine	49	12
Buspirone Hcl	Buspirone Hcl	48	suppressed
Synthroid	Levothyroxine Sodium	48	11
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	48	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	47	15
Clonazepam	Clonazepam	46	suppressed
Lactulose	Lactulose	46	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	46	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	44	29
Celecoxib	Celecoxib	43	14
Citalopram Hbr	Citalopram Hydrobromide	42	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	42	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	42	14
Ventolin Hfa	Albuterol Sulfate	42	suppressed
Lorazepam	Lorazepam	41	15
Nystatin	Nystatin	41	16
Propranolol Hcl	Propranolol Hcl	41	suppressed
Glipizide	Glipizide	39	13
Memantine Hcl	Memantine Hcl	38	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	37	13
Hydralazine Hcl	Hydralazine Hcl	36	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	36	suppressed
Ropinirole Hcl	Ropinirole Hcl	36	suppressed
Azithromycin	Azithromycin	35	23
Quetiapine Fumarate	Quetiapine Fumarate	35	suppressed
Farxiga	Dapagliflozin Propanediol	34	suppressed
Klor-Con M20	Potassium Chloride	34	suppressed
Amiodarone Hcl	Amiodarone Hcl	33	suppressed
Januvia	Sitagliptin Phosphate	33	suppressed
Linzess	Linaclotide	33	suppressed
Prednisone	Prednisone	33	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	33	suppressed
Symbicort	Budesonide/Formoterol Fumarate	32	suppressed
Tresiba Flextouch U-100	Insulin Degludec	31	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	31	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	30	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	30	suppressed
Tizanidine Hcl	Tizanidine Hcl	30	suppressed
Vascepa	Icosapent Ethyl	30	suppressed
Humalog Kwikpen U-100	Insulin Lispro	29	suppressed
Bupropion Xl	Bupropion Hcl	28	suppressed
Risperidone	Risperidone	28	suppressed
Tresiba Flextouch U-200	Insulin Degludec	28	suppressed
Fenofibrate	Fenofibrate	27	suppressed
Ondansetron Odt	Ondansetron	27	12
Carbidopa-Levodopa	Carbidopa/Levodopa	26	suppressed
Digoxin	Digoxin	26	suppressed
Morphine Sulfate Er	Morphine Sulfate	26	suppressed
Nitroglycerin	Nitroglycerin	26	suppressed
Baclofen	Baclofen	25	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Fesoterodine Fumarate Er	Fesoterodine Fumarate	25	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	24	suppressed
Irbesartan	Irbesartan	24	suppressed
Midodrine Hcl	Midodrine Hcl	24	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	23	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	23	suppressed
Lamotrigine	Lamotrigine	23	suppressed
Chlorthalidone	Chlorthalidone	22	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	22	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	22	suppressed
Methotrexate	Methotrexate Sodium	22	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	22	suppressed
Ibuprofen	Ibuprofen	21	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	21	suppressed
Primidone	Primidone	21	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	21	suppressed
Acyclovir	Acyclovir	20	suppressed
Bumetanide	Bumetanide	20	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	20	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	20	suppressed
Xifaxan	Rifaximin	20	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	19	suppressed
Breo Ellipta	Fluticasone/Vilanterol	19	suppressed
Dulera	Mometasone/Formoterol	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	16
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Bupropion Hcl	Bupropion Hcl	18	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	18	suppressed
Invokana	Canagliflozin	18	suppressed
Sucralfate	Sucralfate	17	suppressed
Unifine Safecontrol Pen Needle	Pen Needle,dual Safety,diabetc	17	suppressed
Xultophy 100-3.6	Insulin Degludec/Liraglutide	17	suppressed
Divalproex Sodium	Divalproex Sodium	16	suppressed
Eszopiclone	Eszopiclone	16	suppressed
Fluconazole	Fluconazole	16	suppressed
Gemtesa	Vibegron	16	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	16	suppressed
Carbamazepine	Carbamazepine	15	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	15	suppressed
Ketoconazole	Ketoconazole	15	suppressed
Methocarbamol	Methocarbamol	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Rytary	Carbidopa/Levodopa	15	suppressed
Methenamine Hippurate	Methenamine Hippurate	14	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	13	suppressed
Fentanyl	Fentanyl	13	suppressed
Flecainide Acetate	Flecainide Acetate	13	suppressed
Sotalol	Sotalol Hcl	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Torsemide	Torsemide	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Copaxone	Glatiramer Acetate	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Np Thyroid	Thyroid,pork	12	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	12	suppressed
Trihexyphenidyl Hcl	Trihexyphenidyl Hcl	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Fenofibrate	Fenofibrate,micronized	11	suppressed
Gemfibrozil	Gemfibrozil	11	suppressed
Insulin Aspart Flexpen	Insulin Aspart	11	suppressed
Levemir Flexpen	Insulin Detemir	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Topiramate	Topiramate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error